表紙
市場調查報告書

主動脈覆膜支架:醫療設備的開發平台評估

Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 350910
出版日期 內容資訊 英文 237 Pages
訂單完成後即時交付
價格
Back to Top
主動脈覆膜支架:醫療設備的開發平台評估 Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月20日內容資訊: 英文 237 Pages
簡介

本報告提供全球主動脈覆膜支架市場上主要的開發中產品 (醫療設備)與其臨床實驗的進展調查,再彙整產品特性比較分析 (臨床實驗的各進展階段) ,以及主要企業簡介及代表性產品,近來的市場動靜 (資本交易·產業聯盟等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 主動脈覆膜支架市場概要

第3章 主動脈覆膜支架市場:臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各市場區隔
  • 開發中產品:各地區
  • 開發中產品:法規途徑別
  • 開發中產品:估計認證時期別
  • 開發中產品:現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 主動脈覆膜支架的企業:各臨床實驗階段的開發中產品
  • 主動脈覆膜支架:各臨床實驗階段的開發中產品

第5章 主動脈覆膜支架市場:企業·產品概要

  • Aptus Endosystems, Inc.
    • 開發中產品及進行中的臨床實驗概要
  • BiFlow Medical Ltd
  • BioQ Devices Pty Ltd
  • Bolton Medical, Inc.
  • Cardiatis SA
  • Cardiovate
  • Clinique du Coeur et des Vaisseaux
  • Cook Medical Incorporated
  • Cordis Corporation
  • Cytograft Tissue Engineering, Inc.
  • Endologix, Inc.
  • Endoluminal Sciences Pty Ltd.
  • EndoSpan Ltd
  • Evasc Medical Systems
  • Innovia LLC
  • Lifetech Scientific (Shenzhen) Co., Ltd.
  • LimFlow GmbH
  • Lombard Medical Technologies Inc.
  • Lombard Medical Technologies Plc
  • Medtronic plc
  • MicroPort Scientific Corporation
  • St. Jude Medical, Inc.
  • Terumo Corporation
  • Transcatheter Technologies GmbH
  • TriVascular, Inc.
  • University of California, San Diego
  • University of Limerick
  • University of Rochester
  • W. L. Gore & Associates, Inc.

第6章 主動脈覆膜支架市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0888EPD

GlobalData's Medical Devices sector report, "Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2019" provides an overview of Aortic Stent Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Aortic Stent Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Aortic Stent Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Aortic Stent Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Aortic Stent Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 6
  • 1.2 List of Figures 12

2 Introduction 13

  • 2.1 Aortic Stent Grafts Overview 13

3 Products under Development 14

  • 3.1 Aortic Stent Grafts - Pipeline Products by Stage of Development 14
  • 3.2 Aortic Stent Grafts - Pipeline Products by Segment 15
  • 3.3 Aortic Stent Grafts - Pipeline Products by Territory 16
  • 3.4 Aortic Stent Grafts - Pipeline Products by Regulatory Path 17
  • 3.5 Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 18
  • 3.6 Aortic Stent Grafts - Ongoing Clinical Trials 19

4 Aortic Stent Grafts - Pipeline Products under Development by Companies 20

  • 4.1 Aortic Stent Grafts Companies - Pipeline Products by Stage of Development 20
  • 4.2 Aortic Stent Grafts - Pipeline Products by Stage of Development 22

5 Aortic Stent Grafts Companies and Product Overview 24

  • 5.1 Affluent Medical SA Company Overview 24
    • 5.1.1 Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.2 Altura Medical Inc Company Overview 27
    • 5.2.1 Altura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.3 Angiolutions UG Company Overview 30
    • 5.3.1 Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.4 Aortica Corp Company Overview 31
    • 5.4.1 Aortica Corp Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.5 Ascyrus Medical LLC Company Overview 32
    • 5.5.1 Ascyrus Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.6 BiFlow Medical Ltd Company Overview 35
    • 5.6.1 BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.7 BioQ Devices Pty Ltd Company Overview 36
    • 5.7.1 BioQ Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.8 Cardiatis SA Company Overview 37
    • 5.8.1 Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.9 Cook Medical Inc Company Overview 40
    • 5.9.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.10 Cordis Corp Company Overview 44
    • 5.10.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.11 Cytograft Tissue Engineering Inc (Inactive) Company Overview 48
    • 5.11.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.12 Endologix Inc Company Overview 49
    • 5.12.1 Endologix Inc Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.13 Endoluminal Sciences Pty Ltd. Company Overview 64
    • 5.13.1 Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
  • 5.14 EndoSpan Ltd Company Overview 65
    • 5.14.1 EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.15 Evasc Medical Systems Corp Company Overview 68
    • 5.15.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.16 Hadassah Medical Center Company Overview 69
    • 5.16.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.17 JOTEC GmbH Company Overview 70
    • 5.17.1 JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.18 Kawasumi Laboratories Inc Company Overview 79
    • 5.18.1 Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 79
  • 5.19 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 80
    • 5.19.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 80
  • 5.20 Lombard Medical Technologies Inc. Company Overview 81
    • 5.20.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 81

6 Aortic Stent Grafts- Recent Developments 142

  • 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 142
  • 6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 144
  • 6.3 Nov 13, 2019: Abbott announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020 145
  • 6.4 Nov 12, 2019: W. L. Gore & Associates to reveal new gender insights from real-world aortic data At 2019 VEITHsymposium 146
  • 6.5 Nov 12, 2019: Cook Medical's leadership updates in Asia-pacific reinforce focus on growth and physician relationships 147

7 Appendix 234

  • 7.1 Methodology 234
  • 7.2 About GlobalData 237
  • 7.3 Contact Us 237
  • 7.4 Disclaimer 237

List of Tables

  • Table 1: Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Table 2: Aortic Stent Grafts - Pipeline Products by Segment
  • Table 3: Aortic Stent Grafts - Pipeline Products by Territory
  • Table 4: Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • Table 5: Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • Table 6: Aortic Stent Grafts - Ongoing Clinical Trials
  • Table 7: Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
  • Table 8: Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Table 9: Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Kardiozis - Product Status
  • Table 11: Kardiozis - Product Description
  • Table 12: Affluent Medical SA - Ongoing Clinical Trials Overview
  • Table 13: Kardiozis - Prevention of Type II Endoleaks During Endovascular Treatment of Abdominal Aortic Aneurysm: Endovascular Treatment Versus Combination with Coil Embolisation of the Aneurysmal Sac
  • Table 14: Altura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Altura Endograft System - Product Status
  • Table 16: Altura Endograft System - Product Description
  • Table 17: Altura Medical Inc - Ongoing Clinical Trials Overview
  • Table 18: Altura Endograft System - Kissing Endografts for Peripheral AAA Exclusion: ELEVATE International
  • Table 19: Altura Endograft System - Multi-center Observational Post-market Real World Registry
  • Table 20: Altura Endograft System - The Altura AAA Endograft Safety and Feasibility Study For Exclusion of Abdominal Aortic Aneurysms
  • Table 21: Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Vascular Graft (A3-Shield) - Product Status
  • Table 23: Vascular Graft (A3-Shield) - Product Description
  • Table 24: Aortica Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: BoulEVARd Stent - Product Status
  • Table 26: BoulEVARd Stent - Product Description
  • Table 27: Ascyrus Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Ascyrus Medical Dissection Stent - Product Status
  • Table 29: Ascyrus Medical Dissection Stent - Product Description
  • Table 30: Ascyrus Medical LLC - Ongoing Clinical Trials Overview
  • Table 31: Ascyrus Medical Dissection Stent - Dissected Aorta Repair Through Stent Implantation (DARTS): A Feasibility Study
  • Table 32: Ascyrus Medical Dissection Stent - Dissected Aorta Repair through Stent Implantation (DARTS): A Post-market Registry
  • Table 33: Ascyrus Medical Dissection Stent - Dissected Aorta Repair Through Stent Implantation: A Feasibility, Safety and Performance Trial: DARTS
  • Table 34: BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Status
  • Table 36: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Description
  • Table 37: BioQ Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: BioQ Aortic Stent Graft Assist - Product Status
  • Table 39: BioQ Aortic Stent Graft Assist - Product Description
  • Table 40: Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: Bifurcated Multilayer Flow Modulator Kit - Product Status
  • Table 42: Bifurcated Multilayer Flow Modulator Kit - Product Description
  • Table 43: Cardiatis SA - Ongoing Clinical Trials Overview
  • Table 44: Bifurcated Multilayer Flow Modulator Kit - Evaluation of Safety and Efficacy of the Bifurcated Multilayer Flow Modulator: BMFM
  • Table 45: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Zenith p-Branch - Product Status
  • Table 47: Zenith p-Branch - Product Description
  • Table 48: Cook Medical Inc - Ongoing Clinical Trials Overview
  • Table 49: Zenith p-Branch - Evaluation of Visceral Function Following Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) Using Branch Stent-Grafts
  • Table 50: Zenith p-Branch - Study Assessing Safety and Effectiveness of Perivisceral Aortic Aneurysm Treatment with the Zenith Fenestrated AAA Endovascular Graft and the Zenith p-Branch and the Effects on Organ and Extremity Perfusion
  • Table 51: Zenith p-Branch - Zenith p-Branch Multi-center Study
  • Table 52: Zenith p-Branch - Zenith p-Branch Pivotal Study
  • Table 53: Zenith p-Branch - Zenith p-Branch: Single-center Study
  • Table 54: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: INCRAFT AAA Stent Graft - Product Status
  • Table 56: INCRAFT AAA Stent Graft - Product Description
  • Table 57: Cordis Corp - Ongoing Clinical Trials Overview
  • Table 58: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft Stent Graft System in Subjects with Abdominal Aortic Aneurysms: INSPIRATION
  • Table 59: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Post Approval Study of the INCRAFT Abdominal Aortic Aneurysm (AAA) Stent Graft System in Subjects with Abdominal Aortic Aneurysms
  • Table 60: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Post-market Study of the INCRAFT AAA Stent Graft in Subjects with Abdominal Aortic Aneurysms
  • Table 61: INCRAFT AAA Stent Graft - Korean Registry of Percutaneous EVAR with INCRAFT Stent Graft for the Treatment of Abdominalaortic Aneurysm (K-INCRAFT)
  • Table 62: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 63: LifeJacket AAA Stent Graft - Product Status
  • Table 64: LifeJacket AAA Stent Graft - Product Description
  • Table 65: Endologix Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: AFX2 Bifurcated Endograft System - Product Status
  • Table 67: AFX2 Bifurcated Endograft System - Product Description

List of Figures

  • Figure 1: Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Figure 2: Aortic Stent Grafts - Pipeline Products by Segment
  • Figure 3: Aortic Stent Grafts - Pipeline Products by Territory
  • Figure 4: Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • Figure 5: Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • Figure 6: Aortic Stent Grafts - Ongoing Clinical Trials
Back to Top